secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardion Health Sciences, Inc. (—)
CIK:        0001642375
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001493152-24-019525
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardion Q1 net loss $4.7M; ISS backs Activ sale for $17.2M and dissolution plan
--------------------------------------------------------------------------------

- Q1 revenue $2.999M (-5.8% YoY); net loss $4.747M vs net income $0.533M prior year.
- ISS recommends stockholders vote FOR sale of Activ (Viactiv brand) and plan of liquidation.
- Activ sale for $17.2M cash; special meeting May 23, 2024; close targeted by June 30, 2024.
- Board unanimously recommends approval; expects liquidating distributions above recent stock price.
- Cash and equivalents $5.605M as of March 31, 2024; operating cash use improved to $754.6K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642375/000149315224019525/0001493152-24-019525-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642375/000149315224019525/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-019525

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer